Cellectar Biosciences
CLRB
CLRB
31 hedge funds and large institutions have $3.65M invested in Cellectar Biosciences in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
22% less capital invested
Capital invested by funds: $4.69M → $3.65M (-$1.04M)
Holders
31
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$32.9K | |
| 2 | +$18.9K | |
| 3 | +$11K | |
| 4 |
VF
Virtu Financial
New York
|
+$7.28K |
| 5 |
Jane Street
New York
|
+$6.43K |
Top Sellers
| 1 | -$83K | |
| 2 | -$65.8K | |
| 3 | -$21K | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$18.6K |
| 5 |
Two Sigma Advisers
New York
|
-$7K |